With the evidence of DAPk1-mediated injury in cerebral ischemia and the ability of bioavailable DAPk inhibitors to rescue neuronal death, DAPk1 has emerged as an important drug-discovery target for brain disorders. This evidence concerns the gene DAPK1 and brain disorder.